News
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Redcare Pharmacy announces Managing Board succession: Peter Schmid von Linstow to succeed Olaf Heinrich as part of a planned leadership transition.
Redcare Pharmacy announces Managing Board succession: Peter Schmid von Linstow to succeed Olaf Heinrich as part of a planned leadership transition -
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Redcare Pharmacy N.V.: Change in the Managing Board; Peter Schmid von Linstow to become Chief Executive Officer.
Redcare Pharmacy N.V. appoints Peter Schmid von Linstow as new CEO, replacing Olaf Heinrich. Heinrich to stay on in advisory role. Announcement made by Supervisory Board -
-
-
COMMUNIQUÉ DE PRESSE
Heidelberg Pharma and Huadong Medicine Sign Additional Collaboration Agreement to Jointly Develop New Antibody Drug Conjugates
Heidelberg Pharma and Huadong Medicine sign new collaboration agreement to jointly develop Antibody Drug Conjugates, expanding pipeline with innovative products -
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Heidelberg Pharma and Huadong Medicine Sign Additional Collaboration Agreement to Jointly Develop New Antibody Drug Conjugates
Heidelberg Pharma and Huadong Medicine sign a new collaboration agreement to jointly develop new Antibody Drug Conjugates, broadening their existing partnership and combining proprietary technologies
![Logo de [UNKNOWN]](https://logos.symex.be/img/.jpg)
